The week in review


money stock level up financial

Money was a hot topic in pharmacy this week… for both patients and pharmacists

There was big news in Western Australia, as state Health Minister Roger Cook announced at a Pharmacy Guild forum that pharmacists would be able to administer the dTpa (diphtheria, tetanus and pertussis), MMR (measles, mumps and rubella) and meningococcal (ACWY) vaccines to people aged 16 years and over. The Guild and PSA welcomed the announcement, but the AMA‘s WA branch did not.

GPs continued to criticise pharmacy this week, with the RACGP‘s Dr Harry Nespolon saying the organisation would like to see six-month script lengths, not just the two that continues to be suggested.

Pharmacist politician Emma McBride told the House of Representatives in Canberra that Health Minister Greg Hunt either “just does not get it or does not care” when it comes to patients, particularly in regional areas, who can’t afford to fill their scripts.

We discovered that the use of non-dispensing pharmacists led to less hospitalisations than usual care, but the same outcome was found in trained, collaborative community pharmacists.

Talking of money, PPA welcomed the PSA’s new report, ‘Pharmacists in 2023: Roles and Remuneration,’ which was released during the PSA19 conference. The PSA suggested moves to get $100k salaries for employee pharmacists, and Carlene McMaugh also tackled the issue of pharmacist pay in this week’s AJP Podcast.

PSA opened its new NSW headquarters. Greg Hunt announced four new PBS listings which came into effect on Thursday. And Aspen and the TGA undertook a product defect correction for one batch of Endone 5mg tablets, after Anamorph 30mg was found in one pack. It’s been a busy week.

Previous Merger confirmed
Next Staff Spotlight

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.